CAS Case Digest · Verified against the full award text

CAS 2025/A/11391 — Christopher Vui v. World Rugby

"Vui" · CAS upheld a four-year ban for Samoan rugby player Christopher Vui after confirming 19-norandrosterone presence and rejecting all procedural and substantive defences.

What happened in Vui

Christopher Vui, a professional rugby union player and former captain of the Samoan national team, provided an out-of-competition urine sample on 1 August 2023 during a Samoa training camp. The WADA-accredited SMRTL laboratory in Utah reported an adverse analytical finding (AAF) for 19-norandrosterone (19-NA), a metabolite of the anabolic steroid nandrolone, at an estimated concentration of 7.8 ng/mL. The B Sample confirmed the AAF. World Rugby charged Vui with Presence and Use violations under Regulations 21.2.1 and 21.2.2 ADR. The World Rugby Judicial Committee found the violations proven and imposed a four-year period of ineligibility commencing 27 September 2023. Vui appealed to CAS raising five procedural grounds (laboratory independence, B Sample attendance rights, chain of custody, transparency, and prejudicial delay) and argued the violation was caused by contaminated supplements, seeking either dismissal or a reprimand under the No Significant Fault provision. The CAS Panel dismissed all grounds. It held that the 'fundamental breach' per se rule for B Sample attendance rights is no longer consistent with the 2021 WADA Code, which requires a causative link between any departure and the AAF. No such link was established. The four-year ban was confirmed. The case is significant for definitively closing the door on the 'fundamental breach' doctrine under the 2021 WADA Code framework.

Procedural history of CAS 2025/A/11391

On 1 August 2023, Vui provided an out-of-competition urine sample during a Samoa national team training camp. SMRTL reported an AAF for 19-NA on 26 September 2023. World Rugby provisionally suspended Vui on 27 September 2023 and charged him with Presence and Use violations on 23 December 2023. Vui denied the charges on 16 January 2024. The World Rugby Judicial Committee heard the matter on 25 and 27 November 2024 and 8 January 2025, and on 10 April 2025 issued its decision finding both ADRVs proven and imposing a four-year period of ineligibility deemed to have commenced on 27 September 2023. Vui filed a Statement of Appeal at CAS on 1 May 2025 pursuant to Article R47 of the CAS Code, requesting a three-member panel. The Appeal Brief was filed on 12 June 2025 and World Rugby's Answer on 4 August 2025. A two-day hearing was held by videoconference on 19 and 20 January 2026.

Key holdings in CAS 2025/A/11391

• The concept of 'fundamental breach' operating as a per se rule to invalidate B Sample results without any causative link to the AAF is no longer consistent with the applicable regulatory framework under the 2021 WADA Code, which expressly requires a causation gateway for all departures from International Standards including B Sample attendance rights.
• Dr Eichner's dual role as SMRTL Laboratory Director and paid member of World Rugby's Anti-Doping Advisory Committee (at £750 per annum) did not render SMRTL 'connected' to World Rugby within the meaning of ISL Article 4.4.2.4 so as to undermine its administrative or operational independence, and no reasonably informed observer would harbour reasonable doubts about SMRTL's independence or impartiality.
• ISL Article 5.3.6.2.3 confers only a qualified entitlement to observe 'other steps' of the B Confirmation Procedure — not an absolute right — and the laboratory retains a degree of discretion limited by a threshold of reasonableness, distinct from the mandatory right to attend opening, aliquoting and resealing procedures.
• Although SMRTL's re-analysis of Fraction 8 in Dr Catalani's absence and without advance notice constituted a breach of ISL Article 5.3.6.2.3, the Appellant failed to establish that this exclusion could reasonably have caused the AAF, as required by WADA Code Article 3.2.3 and Regulation 21.3.2.3(c) ADR.
• The Appellant failed to establish on the balance of probabilities that the ADRVs were unintentional, as no contaminated supplement was identified among the eight tested products, no contemporaneous records of supplement use were kept, and the Appellant was the only Samoa player to test positive despite communal supplement use.

How the CAS panel reasoned

The Panel's central analytical move was to trace the evolution of the WADA Code from 2003 to 2021, demonstrating that the causation requirement was clearly imported by the 2009 Code and retained and strengthened in subsequent iterations. The 2021 Code expressly provides in Article 3.2.3(iii) that even deprivation of the right to be notified of the B Sample opening only potentially invalidates an AAF where the athlete establishes a causative link. The Panel also noted the deliberate removal of the word 'fundamental' from the ISL between the 2019 and 2021 iterations. The Panel declined to follow ADO v Z because that body did not operate within the WADA framework and the decision was inconsistent with the 2021 Code. The Panel adopted a practical causation standard requiring the athlete to substantiate a plausible indication of error, while acknowledging a more lenient approach to plausibility where the athlete was excluded from observation. On each alleged breach — initial injection, chromatographic data review, and Fraction 8 re-analysis — the Panel found the Appellant's case rested on speculation without a 'plus factor'. On intent, the Panel applied the 'narrowest of corridors' doctrine from CAS 2016/A/4534, finding that without identifying a contaminated product, the cumulative evidence (negative supplement tests, negative hair analysis, polygraph, character evidence) was insufficient to establish lack of intent on the balance of probabilities.

Why Vui matters in CAS jurisprudence

Vui is the most comprehensive CAS authority to date holding that the 'fundamental breach' per se doctrine for B Sample attendance rights is extinct under the 2021 WADA Code. The Panel's detailed comparative table of WADA Code iterations from 2003 to 2021 and its articulation of a practical causation standard for excluded athletes provides authoritative guidance for future B Sample attendance disputes. The award also confirms that advisory-body membership by a laboratory director, at a nominal fee, does not per se compromise laboratory independence under ISL Article 4.4.2.4.

Cases cited in this award

CAS 2016/A/4534 CAS 2013/A/3112 CAS 2018/A/5584 CAS 2017/A/5016 & 5036 CAS 2014/A/3487 CAS 2024/A/10647

Frequently asked questions about Vui

Did the Vui case abolish the fundamental breach doctrine for B Sample attendance rights?

Yes. The CAS Panel in Vui held that the concept of 'fundamental breach' operating as a per se rule to invalidate B Sample results without any causative link to the AAF is no longer consistent with the 2021 WADA Code. The Panel traced the evolution of the Code from 2003 to 2021, noting that the causation requirement was introduced in 2009 and that Article 3.2.3(iii) of the 2021 Code expressly applies a causation gateway even to deprivation of the right to be notified of the B Sample opening. The Panel also noted the deliberate removal of the word 'fundamental' from the ISL between the 2019 and 2021 iterations.

What causation standard must an athlete meet when excluded from B Sample analysis steps under the Vui ruling?

The Panel held that an athlete must substantiate a plausible indication of error in the B Sample process that, while not observed due to the exclusion, is plausible based on other documentary evidence or broader circumstances raising doubts about the specific B Sample process. Mere speculation or hypothesis without a 'plus factor' raising doubts is insufficient. The Panel acknowledged that a more lenient approach to the degree of plausibility is appropriate where the athlete was prevented from observing the relevant step.

Does a laboratory director serving on a sports federation's advisory committee breach ISL Article 4.4.2.4 independence requirements?

Not automatically, according to Vui. The Panel found that Dr Eichner's membership of World Rugby's Anti-Doping Advisory Committee for a nominal fee of £750 per annum did not render SMRTL 'connected' to World Rugby in a way that affected or could reasonably be seen to affect SMRTL's administrative or operational independence. Key factors were that the Advisory Committee had no decision-making authority over testing or results management, the fee created no material financial dependency, Dr Eichner had no involvement in analysing the Appellant's sample, and the sample was anonymised and processed by other personnel.

Can an athlete in a Vui-type case establish lack of intent without identifying the contaminated supplement?

Only in the rarest of circumstances, and Vui did not qualify. The Panel applied the 'narrowest of corridors' doctrine from CAS 2016/A/4534 and the WADA Code comment to Article 10.2.1.1, which states it is highly unlikely an athlete will prove unintentional conduct without establishing the source of the prohibited substance. In Vui, all eight tested supplements were negative, no contemporaneous records of supplement use were kept, and the Appellant was the only Samoa player to test positive despite communal supplement use, making the contamination theory too speculative to satisfy the balance of probabilities standard.

Topics: Transfers, agents, TPO & sell-on clauses at CAS

Source: official award. This digest was generated by LexXi from the full award text and machine-verified against it — every figure, article and citation above appears in the source. It is an editorial summary, not legal advice. See how ElevenLex verification works.